Your browser doesn't support javascript.
loading
Application of diagnostic and treatment criteria for common variable immunodeficiency disorder.
Ameratunga, Rohan; Storey, Peter; Barker, Russell; Jordan, Anthony; Koopmans, Wikke; Woon, See-Tarn.
Afiliação
  • Ameratunga R; a Department of Virology and Immunology , Auckland Hospital , Auckland , New Zealand.
  • Storey P; b Clinical Immunology , Auckland Hospital , Auckland , New Zealand.
  • Barker R; b Clinical Immunology , Auckland Hospital , Auckland , New Zealand.
  • Jordan A; a Department of Virology and Immunology , Auckland Hospital , Auckland , New Zealand.
  • Koopmans W; b Clinical Immunology , Auckland Hospital , Auckland , New Zealand.
  • Woon ST; a Department of Virology and Immunology , Auckland Hospital , Auckland , New Zealand.
Expert Rev Clin Immunol ; 12(3): 257-66, 2016.
Article em En | MEDLINE | ID: mdl-26623716
ABSTRACT
Common variable immunodeficiency disorder (CVID) is the most frequent symptomatic primary immune deficiency disorder in adults. It probably comprises a spectrum of polygenic disorders, with hypogammaglobulinemia being the overarching feature. While the majority of patients with CVID can be identified with relative ease, a significant proportion can present with minimal symptoms in spite of profound laboratory abnormalities. Here we discuss three patients who were presented to the Auckland Hospital immunoglobulin treatment committee to determine if they qualified for immunoglobulin replacement. Two were asymptomatic with profound laboratory abnormalities while the third patient was severely ill with extensive bronchiectasis. The third patient had less severe laboratory abnormalities compared with the two asymptomatic patients. We have applied four sets of published diagnostic and treatment criteria to these patients to compare their clinical utility. We have chosen these patients from the broad phenotypic spectrum of CVID, as this often illustrates differences in diagnostic and treatment criteria.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquiectasia / Imunodeficiência de Variável Comum / Proteína Transmembrana Ativadora e Interagente do CAML Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquiectasia / Imunodeficiência de Variável Comum / Proteína Transmembrana Ativadora e Interagente do CAML Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Ano de publicação: 2016 Tipo de documento: Article